MD Quote, Financials, Valuation and Earnings

Encompass Health has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of 8.01%. Pediatrix Medical Group's return on equity of -30.86% beat Encompass Health's return on equity of 17.39%.

Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.87%. On the other hand Encompass Health has an analysts' consensus of -- which suggests that it could grow by 23.69%. Given that Encompass Health has higher upside potential than Pediatrix Medical Group, analysts believe Encompass Health is more attractive than Pediatrix Medical Group.

Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.876, suggesting its less volatile than the S&P 500 by 12.393%.

Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.66% to investors and pays a quarterly dividend of $0.17 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Encompass Health pays out 17.16% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Pediatrix Medical Group quarterly revenues are $511.2M, which are smaller than Encompass Health quarterly revenues of $1.4B. Pediatrix Medical Group's net income of $19.4M is lower than Encompass Health's net income of $108.2M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Encompass Health's PE ratio is 22.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 1.84x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

Kindly MD has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of -156.54%. Pediatrix Medical Group's return on equity of -30.86% beat Kindly MD's return on equity of -201.03%.

Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.87%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that Pediatrix Medical Group has higher upside potential than Kindly MD, analysts believe Pediatrix Medical Group is more attractive than Kindly MD.

Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.

Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than Kindly MD quarterly revenues of $647.9K. Pediatrix Medical Group's net income of $19.4M is higher than Kindly MD's net income of -$1M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 2.20x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of -16.13%. Pediatrix Medical Group's return on equity of -30.86% beat The Oncology Institute's return on equity of -163.45%.

Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.87%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could grow by 879.91%. Given that The Oncology Institute has higher upside potential than Pediatrix Medical Group, analysts believe The Oncology Institute is more attractive than Pediatrix Medical Group.

Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than The Oncology Institute quarterly revenues of $99.9M. Pediatrix Medical Group's net income of $19.4M is higher than The Oncology Institute's net income of -$16.1M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 0.04x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.

US Physical Therapy has a net margin of 3.8% compared to Pediatrix Medical Group's net margin of 3.29%. Pediatrix Medical Group's return on equity of -30.86% beat US Physical Therapy's return on equity of 1.67%.

Pediatrix Medical Group has a consensus price target of --, signalling upside risk potential of 18.87%. On the other hand US Physical Therapy has an analysts' consensus of -- which suggests that it could grow by 23.92%. Given that US Physical Therapy has higher upside potential than Pediatrix Medical Group, analysts believe US Physical Therapy is more attractive than Pediatrix Medical Group.

Pediatrix Medical Group has a beta of 1.570, which suggesting that the stock is 56.979% more volatile than S&P 500. In comparison US Physical Therapy has a beta of 1.463, suggesting its more volatile than the S&P 500 by 46.285%.

Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. US Physical Therapy offers a yield of 1.96% to investors and pays a quarterly dividend of $0.44 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. US Physical Therapy pays out 164.43% of its earnings as a dividend.

Pediatrix Medical Group quarterly revenues are $511.2M, which are larger than US Physical Therapy quarterly revenues of $168M. Pediatrix Medical Group's net income of $19.4M is higher than US Physical Therapy's net income of $5.5M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while US Physical Therapy's PE ratio is 52.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.57x versus 2.09x for US Physical Therapy. Usually stocks with elevated PS ratios are considered overvalued.